Mark Brantly, MD
University of Florida
3
3
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+9 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
James Stocks, MD
The University of Texas Health Science Center at Tyler
Shared therapeutic areas:
Worked with same sponsors:
Friedrich Kueppers, MD
Temple University Hospital/Temple Lung Center
Shared therapeutic areas:
Worked with same sponsors:
Charlie Strange, MD
Medical University of South Carolina, Division of Pulmonary and Critical Care Medicine
Shared therapeutic areas:
Worked with same sponsors:
Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Ed Doo, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Ronald G Crystal, MD
Weill Medical College of Cornell University
Shared therapeutic areas:
Konrad E Bloch, MD
University Hospital, Zürich
Shared therapeutic areas:
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Talant M Sooronbaev, MD
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
Environment Effect on Six-Minute Walk Test Performance
All 3 trials loaded